These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 8615863)
41. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes. Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639 [TBL] [Abstract][Full Text] [Related]
42. Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes. Berthou F; Dreano Y; Belloc C; Kangas L; Gautier JC; Beaune P Biochem Pharmacol; 1994 May; 47(10):1883-95. PubMed ID: 8204106 [TBL] [Abstract][Full Text] [Related]
43. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Yamazaki H; Shimada T Arch Biochem Biophys; 1997 Oct; 346(1):161-9. PubMed ID: 9328296 [TBL] [Abstract][Full Text] [Related]
44. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes. Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763 [TBL] [Abstract][Full Text] [Related]
45. Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes. Schuetz EG; Schuetz JD; Strom SC; Thompson MT; Fisher RA; Molowa DT; Li D; Guzelian PS Hepatology; 1993 Nov; 18(5):1254-62. PubMed ID: 8225233 [TBL] [Abstract][Full Text] [Related]
46. Identification of cytochromes P450 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitro. Ufer M; Svensson JO; Krausz KW; Gelboin HV; Rane A; Tybring G Eur J Clin Pharmacol; 2004 May; 60(3):173-82. PubMed ID: 15054565 [TBL] [Abstract][Full Text] [Related]
47. Procarcinogen activation by cytochrome P450 3A4 and 3A5 expressed in Escherichia coli and by human liver microsomes. Yamazaki H; Inui Y; Wrighton SA; Guengerich FP; Shimada T Carcinogenesis; 1995 Sep; 16(9):2167-70. PubMed ID: 7554070 [TBL] [Abstract][Full Text] [Related]
49. Effect of cytochromes P450 chemical inhibitors and monoclonal antibodies on human liver microsomal esterase activity. Polsky-Fisher SL; Cao H; Lu P; Gibson CR Drug Metab Dispos; 2006 Aug; 34(8):1361-6. PubMed ID: 16720683 [TBL] [Abstract][Full Text] [Related]
50. Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b5 interactions. Yamazaki H; Gillam EM; Dong MS; Johnson WW; Guengerich FP; Shimada T Arch Biochem Biophys; 1997 Jun; 342(2):329-37. PubMed ID: 9186495 [TBL] [Abstract][Full Text] [Related]
51. Cytochrome P4502B6 and 2C9 do not metabolize midazolam: kinetic analysis and inhibition study with monoclonal antibodies. Hamaoka N; Oda Y; Hase I; Asada A Br J Anaesth; 2001 Apr; 86(4):540-4. PubMed ID: 11573629 [TBL] [Abstract][Full Text] [Related]
52. Role of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetate. Kobayashi K; Mimura N; Fujii H; Minami H; Sasaki Y; Shimada N; Chiba K Clin Cancer Res; 2000 Aug; 6(8):3297-303. PubMed ID: 10955816 [TBL] [Abstract][Full Text] [Related]
53. Monoclonal antibodies and multifunctional cytochrome P450: drug metabolism as paradigm. Gelboin HV; Krausz K J Clin Pharmacol; 2006 Mar; 46(3):353-72. PubMed ID: 16490812 [TBL] [Abstract][Full Text] [Related]
54. Elucidation of distinct ligand binding sites for cytochrome P450 3A4. Hosea NA; Miller GP; Guengerich FP Biochemistry; 2000 May; 39(20):5929-39. PubMed ID: 10821664 [TBL] [Abstract][Full Text] [Related]
55. Comparative cytochrome P450 -1A1, -2A6, -2B6, -2C, -2D6, -2E1, -3A5 and -4B1 expressions in human larynx tissue analysed at mRNA level. Sarikaya D; Bilgen C; Kamataki T; Topcu Z Biopharm Drug Dispos; 2006 Nov; 27(8):353-9. PubMed ID: 16894644 [TBL] [Abstract][Full Text] [Related]
56. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495 [TBL] [Abstract][Full Text] [Related]
57. Metabolism of sirolimus in the presence or absence of cyclosporine by genotyped human liver microsomes and recombinant cytochromes P450 3A4 and 3A5. Picard N; Djebli N; Sauvage FL; Marquet P Drug Metab Dispos; 2007 Mar; 35(3):350-5. PubMed ID: 17151193 [TBL] [Abstract][Full Text] [Related]
58. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. Smith TJ; Guo Z; Gonzalez FJ; Guengerich FP; Stoner GD; Yang CS Cancer Res; 1992 Apr; 52(7):1757-63. PubMed ID: 1312898 [TBL] [Abstract][Full Text] [Related]
59. Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme. Harris JW; Rahman A; Kim BR; Guengerich FP; Collins JM Cancer Res; 1994 Aug; 54(15):4026-35. PubMed ID: 7913410 [TBL] [Abstract][Full Text] [Related]